Tags

Type your tag names separated by a space and hit enter

Transurethral resection of the prostate in kidney transplant recipients: urological and renal functional outcomes at long-term follow-up.
BJU Int. 2013 Aug; 112(3):386-93.BI

Abstract

OBJECTIVES

To assess prospectively the safety and efficacy of transurethral resection of the prostate (TURP) for the treatment of lower urinary tract symptoms attributable to benign prostatic hyperplasia (BPH) in patients who have undergone renal transplantation (RT). To assess the impact of TURP on renal graft function.

PATIENTS AND METHODS

Urological and renal functional outcomes of TURP performed in RT recipients for treatment of lower urinary tract obstruction attributable to BPH were prospectively assessed in a series of 32 consecutive patients with follow-up of ≥48 months. Maximum urinary flow rate (Qmax) at uroflowmetry, International Prostate Symptom Score (IPSS), post-void residual urine volume (PVR), haemoglobin and serum creatinine (sCr) levels were recorded before TURP and 1, 6, 24 and 48 months after the procedure. The trends in these variables after TURP were evaluated. Early and delayed complications were assessed and graded according to the Clavien classification system.

RESULTS

TURP was performed at a mean of 6 months after RT. No intraoperative complications occurred. Seven postoperative complications were observed (21.9%): two Clavien grade II and five Clavien grade IIIa. Qmax , IPSS and PVR improved significantly after surgery and the improvement was maintained until 48 months. No patient required a repeat TURP during follow-up. SCr levels significantly decreased 1 and 6 months after TURP and did not significantly increase at long-term follow-up.

CONCLUSIONS

TURP for lower urinary tract obstruction attributable to BPH in RT recipients is safe and effective since it improves urinary flow, bladder emptying and related urinary symptoms. TURP allows an early significant improvement of graft function that is maintained at a follow-up of 48 months.

Authors+Show Affiliations

Division of Urology, University of Eastern Piedmont, Novara, Italy. alessandro.volpe@med.unipmn.itNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

23496755

Citation

Volpe, Alessandro, et al. "Transurethral Resection of the Prostate in Kidney Transplant Recipients: Urological and Renal Functional Outcomes at Long-term Follow-up." BJU International, vol. 112, no. 3, 2013, pp. 386-93.
Volpe A, Billia M, Quaglia M, et al. Transurethral resection of the prostate in kidney transplant recipients: urological and renal functional outcomes at long-term follow-up. BJU Int. 2013;112(3):386-93.
Volpe, A., Billia, M., Quaglia, M., Vidali, M., Marchioro, G., Ceratti, G., Sogni, F., De Lorenzis, E., De Angelis, P., Airoldi, A., Stratta, P., & Terrone, C. (2013). Transurethral resection of the prostate in kidney transplant recipients: urological and renal functional outcomes at long-term follow-up. BJU International, 112(3), 386-93. https://doi.org/10.1111/bju.12030
Volpe A, et al. Transurethral Resection of the Prostate in Kidney Transplant Recipients: Urological and Renal Functional Outcomes at Long-term Follow-up. BJU Int. 2013;112(3):386-93. PubMed PMID: 23496755.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Transurethral resection of the prostate in kidney transplant recipients: urological and renal functional outcomes at long-term follow-up. AU - Volpe,Alessandro, AU - Billia,Michele, AU - Quaglia,Marco, AU - Vidali,Matteo, AU - Marchioro,Giansilvo, AU - Ceratti,Giovanni, AU - Sogni,Filippo, AU - De Lorenzis,Elisa, AU - De Angelis,Paolo, AU - Airoldi,Andrea, AU - Stratta,Piero, AU - Terrone,Carlo, Y1 - 2013/03/15/ PY - 2013/3/19/entrez PY - 2013/3/19/pubmed PY - 2013/9/12/medline KW - benign prostatic hyperplasia KW - bladder outlet obstruction KW - lower urinary tract symptoms KW - renal functional outcomes KW - renal transplantation KW - transurethral resection SP - 386 EP - 93 JF - BJU international JO - BJU Int VL - 112 IS - 3 N2 - OBJECTIVES: To assess prospectively the safety and efficacy of transurethral resection of the prostate (TURP) for the treatment of lower urinary tract symptoms attributable to benign prostatic hyperplasia (BPH) in patients who have undergone renal transplantation (RT). To assess the impact of TURP on renal graft function. PATIENTS AND METHODS: Urological and renal functional outcomes of TURP performed in RT recipients for treatment of lower urinary tract obstruction attributable to BPH were prospectively assessed in a series of 32 consecutive patients with follow-up of ≥48 months. Maximum urinary flow rate (Qmax) at uroflowmetry, International Prostate Symptom Score (IPSS), post-void residual urine volume (PVR), haemoglobin and serum creatinine (sCr) levels were recorded before TURP and 1, 6, 24 and 48 months after the procedure. The trends in these variables after TURP were evaluated. Early and delayed complications were assessed and graded according to the Clavien classification system. RESULTS: TURP was performed at a mean of 6 months after RT. No intraoperative complications occurred. Seven postoperative complications were observed (21.9%): two Clavien grade II and five Clavien grade IIIa. Qmax , IPSS and PVR improved significantly after surgery and the improvement was maintained until 48 months. No patient required a repeat TURP during follow-up. SCr levels significantly decreased 1 and 6 months after TURP and did not significantly increase at long-term follow-up. CONCLUSIONS: TURP for lower urinary tract obstruction attributable to BPH in RT recipients is safe and effective since it improves urinary flow, bladder emptying and related urinary symptoms. TURP allows an early significant improvement of graft function that is maintained at a follow-up of 48 months. SN - 1464-410X UR - https://www.unboundmedicine.com/medline/citation/23496755/Transurethral_resection_of_the_prostate_in_kidney_transplant_recipients:_urological_and_renal_functional_outcomes_at_long_term_follow_up_ DB - PRIME DP - Unbound Medicine ER -